Clinical Trials Browser

Phase 1 × OTHER_GOV × CBV protocol × Clear all

NCT05640713 2022-12-07

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

Phase 1 Unknown

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited